j&j covid vaccine: Johnson & Johnson COVID-19 vaccine batch fails quality check
Synopsis A vaccine ingredient made by Emergent BioSolutions -- one of about 10 companies that Johnson and Johnson is using to speed up manufacturing of its recently approved vaccine -- did not meet quality standards, J&J said on Wednesday. J&J had pledged to provide 20 million doses of its vaccine to the US government by the end of March, and 80 million more doses by the end of May. A batch of Johnson and Johnson's COVID-19 vaccine failed quality standards and can't be used, the drug giant has said. The drugmaker didn't say how many doses were lost, and it wasn't clear how the problem would ...